The Scientific Sessions offer five days of prime networking opportunities for attendees through official events such as the ADA Networking Reception, dedicated session breaks, and informal interactions in the Poster and Exhibit Halls.

Full meeting registration for the 82nd Scientific Sessions includes in-person programming in New Orleans on the hottest topics, trials, and trends in diabetes research, prevention, and care, as well as on-demand access to session recordings following the presentations.

The 82nd Scientific Sessions are headed to New Orleans with a dynamic program featuring more than 180 sessions and over 1,000 original abstract presentations covering the hottest topics, trials, and trends in diabetes research, prevention, and care.

The premier meeting in diabetes hits the road for the first time in two years after the COVID-19 pandemic forced the cancellation of in-person gatherings in 2020 and 2021. Virtual attendance is also an option this year.

Vaccination and facemask protocols are based on guidelines from the U.S. Centers for Disease Control and Prevention and may be updated if CDC recommendations change.

A1C is routinely used to monitor glycemic control for patients with diabetes. At the Scientific Sessions, Jay H. Shubrook, DO, FACOFP, FAAFP, BC-ADM, and David B. Sacks, MB ChB, FACP, FRCPath, debated whether point-of-care A1C should be part of the diagnostic toolkit for diabetes.

Marcela Brissova, PhD, Struan F.A. Grant, PhD, Maggie Ng, PhD, and Melina Claussnitzer, PhD, discussed how molecular and genetic studies are providing new insight into the influence of genetics in the development and progression of diabetes.

“The KPMP is all about using the kidney biopsy, which is an old tool, to understand kidney disease in a new way by almost turbocharging the information that we get,” said Jonathan Himmelfarb, MD.

New research uses single-cell technologies to explore the roles of adipocytes, macrophages, beta cells, and fibroblast growth factor-1 in metabolic tissue function. Qiong (Annabel) Wang, PhD, Christopher K. Glass, MD, PhD, Heiko Lickert, PhD, and Michael W. Schwartz, MD, reviewed this work at the Scientific Sessions.

Brian A. Ference, MD, MPhil, MSc, FACC, FESC, Lisa R. Tannock, MD, Jean-Claude Tardif, CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS, and Stephen G. Young, MD, discussed new insights into the role of triglycerides in cardiovascular disease at the Scientific Sessions.